comparemela.com

Latest Breaking News On - C2i genomics - Page 1 : comparemela.com

Veracyte Expects Higher Q4, FY23 Revenue Better Than View; To Acquire C2i Genomics

Biotechnology company, Veracyte, Inc. (VCYT) Monday announced that it expects higher revenue for fourth quarter and fiscal year 2023 mainly due to growth of its Afirma and Decipher businesses.

C2i Genomics and OncoDNA Begin Molecular Residual Disease Testing Across Europe

C2i Genomics and OncoDNA Begin Molecular Residual Disease Testing Across Europe
webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.

C2i Genomics and Gustave Roussy Collaborate to Demonstrate Utility of ctDNA-guided Immunotherapy in Early-Stage Solid Tumors

C2i Genomics and Gustave Roussy Collaborate to Demonstrate Utility of ctDNA-guided Immunotherapy in Early-Stage Solid Tumors
webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.

Collaborative breakthrough for rectal cancer patients

A breakthrough in rectal cancer treatment has been discovered through a collaboration between a cancer intelligence company and the world’s largest and oldest cancer center. It could put an end to the invasive surgery patients may have faced.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.